Dr. Reddy’s in licenses biosimilar for J&J’s multiple myeloma therapy

Dr. Reddy’s (NYSE:RDY) on Thursday announced a licensing agreement with China-based Shanghai Henlius Biotech (OTCPK:SGBCF) to jointly develop and market a biosimilar version of Darzalex, a multiple myeloma therapy marketed by Johnson & Johnson (NYSE:JNJ).

The partnership aims to take